Connection
Heather Moore to Estrogen Antagonists
This is a "connection" page, showing publications Heather Moore has written about Estrogen Antagonists.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.052 |
|
|
|
-
Bardia A, Mayer I, Winer E, Linden HM, Ma CX, Parker BA, Bellet M, Arteaga CL, Cheeti S, Gates M, Chang CW, Fredrickson J, Spoerke JM, Moore HM, Giltnane J, Friedman LS, Chow Maneval E, Chan I, Jhaveri K. The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR?+?/HER2?-) advanced/metastatic breast cancer. Breast Cancer Res Treat. 2023 Jan; 197(2):319-331.
Score: 0.052